Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Landscape of Molecular Diagnostic Tests and Emerging Tools for Tuberculosis and Drug Resistance.

Diagnostics (Basel, Switzerland)·2026
Same author

Occurrence and persistence of aflatoxins in Moroccan durum wheat under contrasting regional climatic conditions: linking environmental factors, aflatoxigenic genes and processing effects.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2026
Same author

Exploring Hydroxytyrosol as a Promising Virucidal Agent: In Silico and In Vitro Insights into Enveloped Viruses.

Current issues in molecular biology·2026
Same author

The Impact of Author Name Ambiguity on Bibliometric Validity. Comment on Ejaz et al. Bibliometric Analysis of Publications on the Omicron Variant from 2020 to 2022 in the Scopus Database Using R and VOSviewer. <i>Int. J. Environ. Res. Public Health</i> 2022, <i>19</i>, 12407.

International journal of environmental research and public health·2026
Same author

Biomarkers of radioresistance in lung cancer: Current insights and future directions (Review).

Molecular medicine reports·2026
Same author

CHD4 and NOX4 expression in thyroid tumor tissues.

Exploration of targeted anti-tumor therapy·2026

Related Experiment Video

Updated: Jul 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based

Youssra Boustany1,2, Abdelilah Laraqui1,3, Sara El Zaitouni1,4

  • 1Research and Biosafety Laboratory, Mohamed V Military Teaching Hospital, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.

Cancer Control : Journal of the Moffitt Cancer Center
|May 17, 2023
PubMed
Summary

Epidermal growth factor receptor (EGFR) mutations are common in Moroccan non-small cell lung cancer (NSCLC) patients, particularly in females and non-smokers. Routine testing using pyrosequencing or Idylla systems can identify patients benefiting from targeted therapies.

Keywords:
IdyllaTMsystemepidermal growth factor receptor mutationsnon-small cell lung cancerpyrosequencing

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K

Related Experiment Videos

Last Updated: Jul 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Diagnostics

Background:

  • Epidermal growth factor receptor (EGFR) mutation status is crucial for non-small cell lung cancer (NSCLC) management.
  • EGFR mutation analysis guides targeted therapy selection, improving patient outcomes.
  • Implementing routine EGFR mutation analysis is essential for Moroccan NSCLC patients.

Purpose of the Study:

  • To present two targeted methods for EGFR mutation identification: pyrosequencing and the Idylla system.
  • To determine the prevalence and spectrum of EGFR mutations in Moroccan NSCLC patients.

Main Methods:

  • Retrospective analysis of 340 NSCLC patients.
  • Somatic EGFR mutations in exons 18-21 were analyzed using pyrosequencing and the Idylla system.

Main Results:

  • Overall, 21.7% of patients had EGFR mutations, with exon 19 deletions (53.4%) and exon 21 substitutions (31%) being most prevalent.
  • EGFR mutations were significantly more common in females (38.4%) and non-smokers (36%).
  • All EGFR-mutated patients had adenocarcinoma, and the tested methods showed high sensitivity and specificity.

Conclusions:

  • There is a critical need for efficient, routine EGFR mutation testing in NSCLC patients.
  • Targeted methods like pyrosequencing and Idylla are suitable for clinical laboratories.
  • Accurate EGFR mutation detection facilitates personalized treatment strategies for NSCLC.